We found an inverse correlation between PDCL3 expression and CD8+ T cell infiltration in ACC, BRCA, and LUAD, suggesting the potential role of PDCL3 in modulating anti-tumor immunity. The gene discussed is CD8A; the disease is adrenal cortex carcinoma.